PMA device
Osteospace
Medilink · Bone Sonometer (MUA, Class II) · First FDA decision Mar 15, 2004, newest Mar 15, 2004Osteoporosis and fragility fractures
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
0
Naming "Osteospace"
MAUDE reports
0
Brand "Osteospace", since 2015
PubMed studies
2
Mentioning "Osteospace"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Osteospace
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- OSTEOSPACEPMA
P010058 · Decided Mar 15, 2004 · 894 days after receipt
Device type: Bone sonometer (MUA) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Osteospace", any status and sponsor, newest update first.
No registered device study names "Osteospace".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Osteospace", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MUA
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Osteospace"[tiab]. The summary above synthesizes these.
- Evaluation of a gel-coupled quantitative ultrasound device for bone status assessment.
Njeh CF, Chen MB, Fan B, et al. · J Ultrasound Med · 2001Evaluation Study, Research Support, Non-U.S. Gov't
- [Effects of different exercises on the bone metabolism level of middle-aged and old women].
Wang C, Yang Z, Chen Y · Sheng Wu Yi Xue Gong Cheng Xue Za Zhi · 2009Comparative Study, English Abstract
Other devices of this type
Also filed under product code MUA.
- Sunlight Omnisense Bone SonometerBeam-Med, Ltd. · PMA 2003
- Omnisense 7000S Ultrasound Bone SonometerBeam-Med, Ltd. · PMA 2003
- Sunlight Omnisense 7000S Ultrasound Bone SonometerBeam-Med, Ltd. · PMA 2002
- Achilles Express UltrasonometerGe Lunar Corp. · PMA 2004
- Mccue Cuba Clinical Ultrasonic Bone Sonometry SystemCooperSurgical, Inc. · PMA 2002
- Achilles Insight UltrasonometerGe Lunar Corp. · PMA 2001
- Ubis 5000 Bone SonometerDiagnostic Medical Systems · PMA 2001
- Dtu-One Ultrasound ScannerOsteometer Meditech A/S · PMA 2000
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.